Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Efficacy of leukotriene antagonist in asthma

Feb. 19, 1997

Pfizer claims 5-LO inhibitors

Feb. 13, 1997

Positive phase II results reported for LiquiVent

Feb. 12, 1997

Dual PDE IV/TNF inhibitors from Pfizer

Feb. 12, 1997

Merck Frosst discloses leukotriene antagonists

Feb. 12, 1997

Dual leukotriene/thromboxane antagonists described by Hokuriku

Feb. 10, 1997

Antiallergic/antiinflammatory agents from Senju

Feb. 7, 1997

Peptide derivatives with antiinflammatory properties described by U.S. researchers

Feb. 7, 1997

Egis develops 5-LO inhibitors

Feb. 6, 1997

CF gene therapy product enters phase II

Feb. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.